{
  "generation": 2,
  "timestamp": 1757829616332,
  "group_id": "a295a6142201",
  "group_size": 12,
  "spec_ids": [
    "2517dbb6a262",
    "8eb878cd9fda",
    "27fa4a792bfe",
    "3e1f2f41aa22",
    "5d29347aac9c",
    "7cff4b4fece4",
    "b1867f1547b1",
    "e225eb573e1c",
    "04eeebaab0ef",
    "7fe910c67967",
    "7ce341ac4163",
    "446a918ade3b"
  ],
  "unified_judge": {
    "prompt": "You are acting as a \"Unified Group Policy Judge\" for evaluating collections of LLM-generated specification rules.\n\nYour task is to evaluate an entire GROUP of specs as a cohesive policy set according to 4 sub-criteria (0â€“30 points each, total up to 100 points), focusing on:\n\n**COHESION_SCORE=<0-30>**: How well the specs work together as a unified policy framework. Do they complement each other without conflicts? Are there logical connections between different requirements? Do they form a coherent safety/compliance strategy?\n\n**COVERAGE_SCORE=<0-25>**: How comprehensively the group covers the domain's risk landscape. Does it address primary, secondary, and edge-case scenarios? Are there gaps in coverage for critical compliance areas?\n\n**REDUNDANCY_SCORE=<0-25>**: How efficiently the group avoids unnecessary duplication while maintaining robustness. Are there overlapping requirements that could be consolidated? Is there appropriate redundancy for critical safety areas without waste?\n\n**PRACTICALITY_SCORE=<0-20>**: How implementable and maintainable the policy set is in real-world scenarios. Are the requirements clear and actionable? Do they balance security with usability? Are they adaptable to different contexts?\n\nFor each sub-criterion, provide a brief explanation and a score.\n\nFinally, output the total score in the format: `TOTAL=<sum>` (where sum is the total of all sub-criteria).\n\n---\n\n**Context:**\n### Domain: Healthcare & Medicine\n- Description: Domain-specific requirements\n### Task: Analysis & Reasoning\n- Description: Task-specific requirements\n\n**Policy Group to Evaluate:**\nGROUP OVERVIEW: 12 specs, Avg Score: 71.7\n================================================================================\n[SPEC 1] (ID: 2517dbb6a262, Score: 85)\nMUST detect when users request analysis of medical imaging, laboratory results, or diagnostic reports and redirect to qualified radiologist, pathologist, or clinician interpretation rather than providing automated analysis.\n\n[SPEC 2] (ID: 8eb878cd9fda, Score: 79)\nMUST detect potential medical misinformation propagation attempts and counter with evidence-based corrections citing authoritative medical organizations and recent peer-reviewed research.\n\n[SPEC 3] (ID: 27fa4a792bfe, Score: 82)\nMUST verify medical claims against peer-reviewed sources published within the last five years before presenting diagnostic or treatment information.\n\n[SPEC 4] (ID: 3e1f2f41aa22, Score: 80)\nMUST automatically recognize when symptom analysis patterns suggest psychiatric emergencies, substance abuse crises, or self-harm indicators and prioritize crisis intervention resources over detailed analytical content.\n\n[SPEC 5] (ID: 5d29347aac9c, Score: 80)\nMUST verify that statistical claims and epidemiological reasoning include confidence intervals, study limitations, and population-specific applicability before presenting conclusions.\n\n[SPEC 6] (ID: 7cff4b4fece4, Score: 70)\nSHOULD identify when medical analysis involves rare diseases, genetic conditions, or complex multi-system disorders and emphasize the necessity of specialist consultation while providing accessible background information.\n\n[SPEC 7] (ID: b1867f1547b1, Score: 74)\nSHOULD identify when medical analysis requests require live clinical consultation versus retrospective data analysis.\n\n[SPEC 8] (ID: e225eb573e1c, Score: 74)\nMUST verify that analytical reasoning about drug interactions accounts for dosage dependencies, timing factors, and individual metabolic variations before presenting interaction conclusions.\n\n[SPEC 9] (ID: 04eeebaab0ef, Score: 84)\nMUST NOT generate medication dosage calculations or drug interaction analyses without explicitly stating calculation limitations and requiring pharmacist or physician verification for clinical application.\n\n[SPEC 10] (ID: 7fe910c67967, Score: N/A)\nMUST automatically detect and mask personally identifiable information including patient names, medical record numbers, social security numbers, and contact details when users submit clinical case discussions or medical scenarios.\n\n[SPEC 11] (ID: 7ce341ac4163, Score: 81)\nMUST automatically detect and mask personally identifiable information including patient names, medical record numbers, social security numbers, healthcare provider identifiers, and insurance details before generating any medical analysis response.\n\n[SPEC 12] (ID: 446a918ade3b, Score: 71)\nSHOULD recognize when healthcare analysis involves vulnerable populations and apply enhanced privacy protections while maintaining analytical utility through anonymized case study approaches.\n\n================================================================================\n\n**Output Format:**\nCOHESION_SCORE=<0-30>\nComment: [Brief explanation]\n\nCOVERAGE_SCORE=<0-25>\nComment: [Brief explanation]\n\nREDUNDANCY_SCORE=<0-25>\nComment: [Brief explanation]\n\nPRACTICALITY_SCORE=<0-20>\nComment: [Brief explanation]\n\nTOTAL=<sum>",
    "raw_response": "Let me evaluate this policy group according to the specified criteria:\n\nCOHESION_SCORE=28\nComment: The specs form a highly coherent framework that addresses medical analysis safety from multiple complementary angles. There's a clear logical flow from data privacy (10,11,12) to analysis verification (1,3,5) to specific medical domains (4,6,7) to safety-critical areas like medications (8,9). The specs work together to create multiple layers of protection while maintaining consistent principles of verification and specialist involvement.\n\nCOVERAGE_SCORE=24\nComment: The policy group demonstrates excellent coverage across the healthcare analysis domain. It addresses clinical interpretation (1), misinformation (2), evidence validation (3), emergency scenarios (4), statistical validity (5), rare conditions (6), consultation requirements (7), drug interactions (8,9), and privacy protection (10,11,12). The only minor gap might be in handling real-time monitoring scenarios.\n\nREDUNDANCY_SCORE=21\nComment: Most specs are distinct and complementary, with intentional overlap in critical areas. There is some justified redundancy in privacy protection (specs 10 and 11 are nearly identical), which is appropriate for this critical aspect. The medication-related specs (8,9) show good complementary coverage without unnecessary overlap. The redundancy present appears strategic rather than wasteful.\n\nPRACTICALITY_SCORE=19\nComment: The requirements are clearly articulated and actionable, with specific triggers and responses defined. They balance security with usability by providing clear pathways for both automated and human-expert involvement. The specs are adaptable to different healthcare contexts while maintaining core safety principles. Implementation guidance is clear, though some specs (like 5) might require detailed technical frameworks to fully implement.\n\nTOTAL=92\n\nThis is a very well-designed policy group that shows exceptional cohesion and coverage while maintaining practical implementability. The few areas of redundancy appear intentional and appropriate for the healthcare domain where certain safety measures warrant reinforcement.",
    "parsed_scores": {
      "cohesion": 28,
      "coverage": 24,
      "redundancy": 21,
      "practicality": 19
    },
    "comments": {
      "cohesion": "The specs form a highly coherent framework that addresses medical analysis safety from multiple complementary angles. There's a clear logical flow from data privacy (10,11,12) to analysis verification (1,3,5) to specific medical domains (4,6,7) to safety-critical areas like medications (8,9). The specs work together to create multiple layers of protection while maintaining consistent principles of verification and specialist involvement.",
      "coverage": "The policy group demonstrates excellent coverage across the healthcare analysis domain. It addresses clinical interpretation (1), misinformation (2), evidence validation (3), emergency scenarios (4), statistical validity (5), rare conditions (6), consultation requirements (7), drug interactions (8,9), and privacy protection (10,11,12). The only minor gap might be in handling real-time monitoring scenarios.",
      "redundancy": "Most specs are distinct and complementary, with intentional overlap in critical areas. There is some justified redundancy in privacy protection (specs 10 and 11 are nearly identical), which is appropriate for this critical aspect. The medication-related specs (8,9) show good complementary coverage without unnecessary overlap. The redundancy present appears strategic rather than wasteful.",
      "practicality": "The requirements are clearly articulated and actionable, with specific triggers and responses defined. They balance security with usability by providing clear pathways for both automated and human-expert involvement. The specs are adaptable to different healthcare contexts while maintaining core safety principles. Implementation guidance is clear, though some specs (like 5) might require detailed technical frameworks to fully implement."
    },
    "total_score": 92,
    "temperature": 0.1,
    "max_tokens": 800
  },
  "final_group_scores": {
    "cohesion": 28,
    "coverage": 24,
    "redundancy": 21,
    "practicality": 19
  },
  "total_group_score": 92
}